{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:35:30Z","timestamp":1774524930914,"version":"3.50.1"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:p>OBJECTIVES. The goals were (1) to compare pediatricians' heptavalent pneumococcal conjugate vaccine shortage experience and adherence to shortage recommendations during 2 heptavalent pneumococcal conjugate vaccine shortages, (2) to assess factors associated with nonadherence to second shortage recommendations, and (3) to assess opinions about national immunization policy during vaccine shortages.<\/jats:p>\n               <jats:p>METHODS. We mailed surveys to all pediatrician immunization providers in the greater Cincinnati, Ohio, metropolitan area. We assessed heptavalent pneumococcal conjugate vaccine supply and immunization practices during the shortages and provider attitudes regarding immunization shortage policy.<\/jats:p>\n               <jats:p>RESULTS. The response rate was 61% (171 of 282 providers). Most pediatricians experienced heptavalent pneumococcal conjugate vaccine shortages (first shortage: 86%; second shortage: 84%). The rate of adherence to recommendations to defer the fourth heptavalent pneumococcal conjugate vaccine dose for healthy children was significantly higher during the second shortage, compared with the first shortage (first shortage: 62%; second shortage: 89%). Adherence to recommendations to administer the fourth dose to high-risk children remained unchanged (first shortage: 43%; second shortage: 45%). Controlling for other factors, pediatricians who reported a severe second shortage had greater odds of not fully vaccinating high-risk children, compared with those who reported no shortage. Contrary to recommendations, many pediatricians did not maintain tracking systems during the heptavalent pneumococcal conjugate vaccine shortages (first shortage: 37%; second shortage: 46%). Most pediatricians (91%) thought that national vaccine shortage recommendations were needed to protect them from liability.<\/jats:p>\n               <jats:p>CONCLUSIONS. The rate of adherence to recommendations to defer heptavalent pneumococcal conjugate vaccine doses for healthy children increased significantly from the first shortage to the second shortage. The nonadherent practice of deferring the fourth dose for high-risk children was associated with more severe shortages and, potentially, an inability to vaccinate.<\/jats:p>","DOI":"10.1542\/peds.2007-0359","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T00:54:14Z","timestamp":1185238454000},"page":"e401-e409","source":"Crossref","is-referenced-by-count":7,"title":["Pediatricians' Adherence to Pneumococcal Conjugate Vaccine Shortage Recommendations in 2 National Shortages"],"prefix":"10.1542","volume":"120","author":[{"given":"Gerry","family":"Fairbrother","sequence":"first","affiliation":[{"name":"Center for Epidemiology and Biostatistics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Broder","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Allen","family":"Staat","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schwartz","sequence":"additional","affiliation":[{"name":"National Vaccine Program Office, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Heubi","sequence":"additional","affiliation":[{"name":"Center for Epidemiology and Biostatistics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Hiratzka","sequence":"additional","affiliation":[{"name":"Center for Epidemiology and Biostatistics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances J.","family":"Walker","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardythe L.","family":"Morrow","sequence":"additional","affiliation":[{"name":"Center for Epidemiology and Biostatistics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"2021120901510281000_R1","doi-asserted-by":"crossref","unstructured":"Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA.\u20082003;290:3122\u20133128","DOI":"10.1001\/jama.290.23.3122"},{"key":"2021120901510281000_R2","doi-asserted-by":"crossref","unstructured":"Klein JO, Myers MG. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions. Clin Infect Dis.\u20082006;42(suppl 3):S97\u2013S103","DOI":"10.1086\/499585"},{"key":"2021120901510281000_R3","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics.\u20082000;106:362\u2013366","DOI":"10.1542\/peds.106.2.362"},{"key":"2021120901510281000_R4","unstructured":"Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.\u20082000;49(RR-9):1\u201338"},{"key":"2021120901510281000_R5","unstructured":"Centers for Disease Control and Prevention. Notice to readers: decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep.\u20082001;50:783\u2013784"},{"key":"2021120901510281000_R6","unstructured":"Centers for Disease Control and Prevention. Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep.\u20082003;52:446\u2013447"},{"key":"2021120901510281000_R7","unstructured":"Centers for Disease Control and Prevention. Notice to readers: limited supply of pneumococcal conjugate vaccine: suspension of recommendation for fourth dose. MMWR Morb Mortal Wkly Rep.\u20082004;53:108\u2013109"},{"key":"2021120901510281000_R8","unstructured":"Centers for Disease Control and Prevention. Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep.\u20082004;53:851\u2013852"},{"key":"2021120901510281000_R9","unstructured":"Advisory Committee on Immunization Practices. Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine in a setting of a vaccine shortage. MMWR Morb Mortal Wkly Rep.\u20082001;50:1140\u20131142"},{"key":"2021120901510281000_R10","unstructured":"Overturf G. PCV7 shortage reaches critical level: new recommendations issued. AAP News.\u20082002;20:1\u201311"},{"key":"2021120901510281000_R11","unstructured":"Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep.\u20082004;53:177\u2013178"},{"key":"2021120901510281000_R12","unstructured":"Centers for Disease Control and Prevention. Notice to readers: updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose. MMWR Morb Mortal Wkly Rep.\u20082004;53:589\u2013590"},{"key":"2021120901510281000_R13","doi-asserted-by":"crossref","unstructured":"Broder KR, MacNeil A, Malone S, et al. Who's calling the shots? Pediatricians' adherence to the 2001\u20132003 pneumococcal conjugate vaccine-shortage recommendations. Pediatrics.\u20082005;115:1479\u20131487","DOI":"10.1542\/peds.2004-1617"},{"key":"2021120901510281000_R14","unstructured":"Conover W. Practical Nonparametic Statistics. 2nd ed. New York, NY: Wiley; 1980"},{"key":"2021120901510281000_R15","doi-asserted-by":"crossref","unstructured":"Freed GL, Davis MM, Clark SJ. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA.\u20082003;289:575\u2013578","DOI":"10.1001\/jama.289.5.575"},{"key":"2021120901510281000_R16","doi-asserted-by":"crossref","unstructured":"Stokley S, Santoli JM, Willis B, Kelley V, Vargas-Rosales A, Rodewald LE. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med.\u20082004;26:15\u201321","DOI":"10.1016\/j.amepre.2003.09.010"},{"key":"2021120901510281000_R17","doi-asserted-by":"crossref","unstructured":"Yawn BP, Schroeder C, Wollan P, Rocca L, Zimmerman R, Bardenheier B. Immediate and longer term impact of the varicella shortage on children 18 and 24 months of age in a community population. BMC Fam Pract.\u20082006;7:51","DOI":"10.1186\/1471-2296-7-51"},{"key":"2021120901510281000_R18","doi-asserted-by":"crossref","unstructured":"Mody L, Langa KM, Malani PN. Impact of the 2004\u20132005 influenza vaccine shortage on immunization practices in long-term care facilities. Infect Control Hosp Epidemiol.\u20082006;27:383\u2013387","DOI":"10.1086\/503179"},{"key":"2021120901510281000_R19","doi-asserted-by":"crossref","unstructured":"Allred NJ, Stevenson JM, Kolasa M, et al. Using registry data to evaluate the 2004 pneumococcal conjugate vaccine shortage. Am J Prev Med.\u20082006;30:347\u2013350","DOI":"10.1016\/j.amepre.2005.11.011"},{"key":"2021120901510281000_R20","doi-asserted-by":"crossref","unstructured":"Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet.\u20082006;368:1495\u20131502","DOI":"10.1016\/S0140-6736(06)69637-2"},{"key":"2021120901510281000_R21","doi-asserted-by":"crossref","unstructured":"Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol.\u20081997;50:1129\u20131136","DOI":"10.1016\/S0895-4356(97)00126-1"},{"key":"2021120901510281000_R22","unstructured":"Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res.\u20082001;35:1347\u20131355"},{"key":"2021120901510281000_R23","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract.\u20082003;16:363\u2013371","DOI":"10.3122\/jabfm.16.5.363"},{"key":"2021120901510281000_R24","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Kim CS, Clark SJ. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine. Pediatrics.\u20082003;112:521\u2013526","DOI":"10.1542\/peds.112.3.521"},{"key":"2021120901510281000_R25","doi-asserted-by":"crossref","unstructured":"Lane KS, Chu SY, Santoli JM. The United States pediatric vaccine stockpile program. Clin Infect Dis.\u20082006;42(suppl 3):S125\u2013S129","DOI":"10.1086\/499591"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/e401\/1119516\/zpe0080700e401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/e401\/1119516\/zpe0080700e401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T07:53:03Z","timestamp":1639036383000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/2\/e401\/70366\/Pediatricians-Adherence-to-Pneumococcal-Conjugate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,8,1]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0359","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}